SSR 182289A

Known as: SSR-182289A, SSR182289A 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1968-2004
012319682004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SSR182289A 1 is the result of a rational optimisation process leading to an orally active thrombin inhibitor. The structure… (More)
Is this relevant?
2004
2004
BACKGROUND AND OBJECTIVES The purpose of this work was to investigate whether thrombolysis induced by recombinant tissue… (More)
Is this relevant?
2004
2004
6. S. F. Khalilova and I. A. Poplavskaya, Izv. Akad. Nauk Kazakh SSR, Ser. Khim., No. 3, 39-43 (1979)~ 7. I.N. Azerbaev, I. A… (More)
Is this relevant?
2003
2003
N-[3-[[[(1S)-4-(5-Amino-2-pyridinyl)-1-[[4-difluoromethylene)-1-piperidinyl]carbonyl]butyl]amino]sulfonyl][1,1'-biphenyl]-2-yl… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
SSR182289A competitively inhibits human thrombin (K(i) = 0.031 +/- 0.002 microM) and shows good selectivity with respect to other… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 4
Is this relevant?
1977
1977
 
Is this relevant?
1968
1968
  • R R Magdiev
  • Meditsinskaia parazitologiia i parazitarnye…
  • 1968
 
Is this relevant?